Review of Cannabis Health Risks: Psychosis Link Strong, Withdrawal Syndrome Real, Gateway Theory Debated
A comprehensive review found strong evidence linking cannabis to psychosis and other mental health conditions, supported the existence of a cannabis withdrawal syndrome, and called for more research on effective prevention and treatment strategies.
Quick Facts
What This Study Found
This review covered multiple dimensions of cannabis health effects and comorbidity. The physiological and neurological effects of cannabis were reviewed alongside prevalence data and the gateway drug hypothesis.
The review found strong support for a link between cannabis and the development and exacerbation of psychosis. Links to anxiety and depression were also supported, though the evidence was less definitive.
Regarding dependence, the review supported the existence of a cannabis withdrawal syndrome with diagnostic criteria. The question of whether cannabis serves as a "gateway" to harder drugs was discussed but not definitively resolved.
The authors called for further research into the neurochemical processes underlying cannabis-mental health relationships, the social factors driving increasing youth cannabis use, and systematic evaluation of prevention and treatment programs through randomized controlled trials.
Key Numbers
Strong evidence for cannabis-psychosis link. Support for cannabis withdrawal syndrome as a diagnosable condition. Cannabis identified as one of the most commonly used illicit drugs globally.
How They Did This
Narrative review examining published literature on cannabis physiological effects, prevalence, gateway hypothesis, dependence criteria, withdrawal syndrome, and comorbidity with psychosis, anxiety, and depression. Also reviewed public health prevention and treatment programs.
Why This Research Matters
By addressing the full spectrum of cannabis health risks in a single review, this paper provided a comprehensive resource for clinicians and policymakers. The emphasis on cannabis being potentially more harmful than traditionally perceived, particularly regarding mental health, reflected a shift in research consensus in the mid-2000s.
The Bigger Picture
This review captured a pivotal moment when the scientific community was reassessing the relative harmfulness of cannabis, particularly regarding mental health effects. The call for randomized controlled trials of prevention and treatment interventions reflected the growing recognition that cannabis-related problems deserved the same research attention as alcohol and other drugs.
What This Study Doesn't Tell Us
As a narrative review, it did not systematically grade the quality of evidence for each claim. The causal direction of the cannabis-mental health relationship was acknowledged as uncertain. Prevention program evidence was limited.
Questions This Raises
- ?What are the specific neurochemical mechanisms by which cannabis contributes to psychosis?
- ?Why is cannabis use increasing among young people, and what prevention strategies are effective?
Trust & Context
- Key Stat:
- Strong support found for a link between cannabis and the development and exacerbation of psychosis
- Evidence Grade:
- Comprehensive narrative review covering multiple health domains. Provides a useful overview but does not use systematic review methodology.
- Study Age:
- Published in 2005. Subsequent research has generally strengthened the evidence for the cannabis-psychosis link and has better characterized cannabis withdrawal syndrome.
- Original Title:
- Comorbidity: cannabis and complexity.
- Published In:
- Journal of psychiatric practice, 11(3), 161-76 (2005)
- Authors:
- Raphael, Beverley, Wooding, Sally, Stevens, Garry, Connor, Jason
- Database ID:
- RTHC-00203
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Is cannabis really less harmful than other drugs?
This review challenged that assumption, noting that while cannabis effects have traditionally been seen as less harmful than alcohol or cocaine, current research supports real health risks including psychosis, anxiety, depression, and dependence with withdrawal symptoms.
Is there a cannabis withdrawal syndrome?
Yes. This review supported the existence of a diagnosable cannabis withdrawal syndrome, including specific diagnostic criteria. While generally less severe than withdrawal from alcohol or opioids, it is a real clinical phenomenon that can complicate efforts to quit.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- creativity-without-weed-quitting-artist-musician
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- hobbies-after-quitting-weed
- identity-after-quitting-weed
- leaving-stoner-culture-identity
- money-saved-quitting-weed-calculator
- nervous-system-weed-withdrawal-fight-flight
- one-year-sober-weed
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-weight-loss-gain
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- weed-withdrawal-tracker
- cannabis-recovery-community-support-group-compare
- why-does-weed-make-you-paranoid-amygdala
- why-weed-makes-me-anxious-now-not-before
- thc-and-weightlifting-muscle-growth-recovery
- thc-and-ssris-cannabis-antidepressants
- thc-and-benzodiazepines-dangerous-overlap
- thc-and-antipsychotics-complicated-relationship
- cannabis-and-socializing-only-use-around-others
- cannabis-recovery-devotional-30-days-scripture
- celebrate-recovery-vs-marijuana-anonymous
Cite This Study
https://rethinkthc.com/research/RTHC-00203APA
Raphael, Beverley; Wooding, Sally; Stevens, Garry; Connor, Jason. (2005). Comorbidity: cannabis and complexity.. Journal of psychiatric practice, 11(3), 161-76.
MLA
Raphael, Beverley, et al. "Comorbidity: cannabis and complexity.." Journal of psychiatric practice, 2005.
RethinkTHC
RethinkTHC Research Database. "Comorbidity: cannabis and complexity." RTHC-00203. Retrieved from https://rethinkthc.com/research/raphael-2005-comorbidity-cannabis-and-complexity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.